Please use this identifier to cite or link to this item:

TitleZymomonas mobilis as an emerging biotechnological chassis for the production of industrially relevant compounds
Author(s)Braga, Adelaide
Gomes, Daniela
Costa, João Manuel Rainha
Amorim, Cláudia
Cardoso, Beatriz
Gudiña, Eduardo José
Silvério, Sara Isabel Cruz
Rodrigues, Joana Lúcia Lima Correia
Rodrigues, L. R.
Industrial chassis
Metabolic Engineering
Synthetic biology
Zymomonas mobilis
Issue date16-Dec-2021
JournalBioresources and Bioprocessing
CitationBraga, Adelaide; Gomes, Daniela; , J. Rainha; Amorim, Cláudia; Cardoso, B.; Gudiña, Eduardo J.; Silvério, Sara C.; Rodrigues, Joana L.; Rodrigues, Lígia R., Zymomonas mobilis as an emerging biotechnological chassis for the production of industrially relevant compounds. Bioresources and Bioprocessing, 8(128), 2021
Abstract(s)Zymomonas mobilis is a well-recognized ethanologenic bacterium with outstanding characteristics which make it a promising platform for the biotechnological production of relevant building blocks and fine chemicals compounds. In the last years, research has been focused on the physiological, genetic, and metabolic engineering strategies aiming at expanding Z. mobilis ability to metabolize lignocellulosic substrates toward biofuel production. With the expansion of the Z. mobilis molecular and computational modeling toolbox, the potential of this bacterium as a cell factory has been thoroughly explored. The number of genomic, transcriptomic, proteomic, and fluxomic data that is becoming available for this bacterium has increased. For this reason, in the forthcoming years, systems biology is expected to continue driving the improvement of Z. mobilis for current and emergent biotechnological applications. While the existing molecular toolbox allowed the creation of stable Z. mobilis strains with improved traits for pinpointed biotechnological applications, the development of new and more flexible tools is crucial to boost the engineering capabilities of this bacterium. Novel genetic toolkits based on the CRISPR-Cas9 system and recombineering have been recently used for the metabolic engineering of Z. mobilis. However, they are mostly at the proof-of-concept stage and need to be further improved.
Publisher version
AccessOpen access
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_55116_1.pdf1,7 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID